CD4+T and CD8+T cells profile in lung inflammation and fibrosis: targets and potential therapeutic drugs

Pulmonary fibrosis is an interstitial lung disease characterized by chronic progressive fibrosis. It is associated with fibrocyte proliferation and collagen deposition, leading to severe, irreversible lung function decline. Despite extensive research, the diagnosis and treatment of pulmonary fibrosi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaobo Sun, Xinwen Zhang, Yuhan He, Xueting Du, Qian Cai, Zhihong Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Immunology
Subjects:	CD4 + T cells CD8 + T cells inflammation pulmonary fibrosis drug and target
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1562892/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO
by: T. V. Tyrinova, et al.
Published: (2012-05-01)

Association of Absolute Lymphocyte Count and Circulating CD4+ and CD8+ T-Cells with Positive Clinical Outcome in Survivors of Cancer: An Observational Study
by: Suresh Rao, et al.
Published: (2019-07-01)

Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells
by: Susan N Christo, et al.
Published: (2024-01-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

Two chemotherapeutic agents expand stem-like CD62L+CD8+ T cells in antitumor immune responses
by: Xiaokang Ruan, et al.
Published: (2025-04-01)

CD161+CD127+CD8+ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
by: Jingjing Qu, et al.
Published: (2024-12-01)

Systematic exploration of the molecular characteristics of CD8+ T cells to predict the response to immunotherapy and the prognosis of patients with colon adenocarcinoma
by: Xin Shen, et al.
Published: (2024-12-01)

The significance of CD4+ and CD8+ T lymphocyte infiltration in esophageal squamous cell carcinoma
by: Jiang Y. Zhao, et al.
Published: (2025-01-01)

Ferroptosis of T cell in inflammation and tumour immunity
by: Xueli Xia, et al.
Published: (2025-03-01)

Discovering biomarkers associated with infiltration of CD8+ T cells and tumor-associated fibrosis in colon adenocarcinoma using single-cell RNA sequencing and gene co-expression network
by: Jinning Zhang, et al.
Published: (2025-03-01)

CD73+CD8+ T cells define a subset with anti-tumor potential in DLBCL patients
by: Lingyu Zhang, et al.
Published: (2025-05-01)

FEATURES OF CD34+ CELL KINETICS IN CHILDREN WITH DIFFERENT KINDS OF INFLAMMATION
by: I. I. Dolgushin, et al.
Published: (2014-07-01)

The unreversible reduced but persistent activated NK and CD8+ T cells in severe/critical COVID-19 during omicron pandemic in China
by: Ling Qin, et al.
Published: (2023-12-01)

Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype
by: Jingjing Qu, et al.
Published: (2025-07-01)

Targeting the CD39/CD73 pathway: New insights into cardiac fibrosis and inflammation in female cardiac surgery patients
by: Eitezaz Mahmood, et al.
Published: (2025-06-01)

Global research trends in the relationship between influenza and CD4+ T/CD8+ T cells: A bibliometric analysis
by: Yanping Zong, et al.
Published: (2024-12-01)

HMGB1 regulates the activation of dendritic cells and CD4+ T cell responses through the modulation of autophagy in bleomycin-induced pulmonary fibrosis
by: Xiuhua Liu, et al.
Published: (2025-05-01)

CD4+/CD8+ lymphocyte ratio as a biomarker of morbidity and severity in patients with moderate and severe COVID-19
by: D. Torres-Gonzales, et al.
Published: (2025-07-01)

Early Activation of Lung CD8+ T Cells After Immunization with Live Plasmodium berghei Malaria Sporozoites
by: Roos van Schuijlenburg, et al.
Published: (2025-03-01)

Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme
by: Hong-Liang Wang, et al.
Published: (2025-05-01)

Research of subpopulation CD3+ CD4- CD8- double-negative T lymphocytes in kidney transplant recipients
by: S. V. Zybleva, et al.
Published: (2020-03-01)

Therapeutic mucosal vaccination of herpes simplex virus type 2 infected guinea pigs with an adenovirus-based vaccine expressing the ribonucleotide reductase 2 and glycoprotein D induces local tissue-resident CD4+ and CD8+ TRM cells associated with protection against recurrent genital herpes
by: Afshana Quadiri, et al.
Published: (2025-03-01)

Expansion of CD57+ CD8 T cells in common variable immunodeficiency with hepatopathy and CMV infection
by: Patrick Bez, et al.
Published: (2025-05-01)

Periplakin Attenuates Liver Fibrosis via Reprogramming CD44Low Cells into CD44High Liver Progenitor CellsSummary
by: Lichao Zhang, et al.
Published: (2025-01-01)

Intrahepatic CD161hiCD8+T Cell Recruitment Has a Pathogenetic Potential in Chronic HBV Infection
by: Jianfei Li, et al.
Published: (2025-01-01)

CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
by: Rongpu Liang, et al.
Published: (2025-02-01)

Single-Nucleus and Bulk RNA Sequencing Reveals the Involvement of Natural Killer and CD8+ T Cells in the Progression of Androgenetic Alopecia
by: Fu H, et al.
Published: (2025-05-01)

CD36 promotes iron accumulation and dysfunction in CD8 T cells via the p38-CEBPB-TfR1 axis in earlystage hepatocellular carcinoma
by: Yifei Qin, et al.
Published: (2025-07-01)

The potential role of biomarkers CD28 and PF4 in the pathogenesis of idiopathic pulmonary fibrosis and their impact on the prognosis: an immune microenvironment analysis
by: Li Yan, et al.
Published: (2025-06-01)

Targeting CD30L in B-cell non-Hodgkin lymphoma: novel peptide conjugates and their therapeutic potential
by: Chaowen Shi, et al.
Published: (2025-07-01)

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines
by: Cynthia González Muñoz, et al.
Published: (2025-05-01)

Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity
by: Huan Liu, et al.
Published: (2025-05-01)

CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
by: Hanghang Xie, et al.
Published: (2024-12-01)

IL-6 and CD4+/CD8+ are Important Indicators for Predicting Prognosis in Elderly AECOPD Patients: A Retrospective Study
by: Liu Q, et al.
Published: (2025-02-01)

Identification of a risk model for prognostic and therapeutic prediction in bladder urothelial carcinoma based on infiltrating CD8+ T cells
by: Ligang Ma, et al.
Published: (2025-12-01)

Cross‐presentation of malaria antigen by brain microvessels: why CD8+ T cells are critical for the pathogenesis of experimental cerebral malaria
by: Katsuyuki Yui
Published: (2013-06-01)

Dysfunctional Senescent Herpes Simplex Virus-Specific CD57<sup>+</sup>CD8<sup>+</sup> T Cells Are Associated with Symptomatic Recurrent Ocular Herpes in Humans
by: Aziz A. Chentoufi, et al.
Published: (2025-04-01)

Engineering of CD8+ T cells with an HIV-specific synthetic notch receptor to secrete broadly therapeutic antibodies for combining antiviral humoral and cellular immune responses
by: Lina Meng, et al.
Published: (2025-04-01)

The interaction of macrophages and CD8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection
by: Qianting Yang, et al.
Published: (2023-12-01)

Metabolic alterations driven by LDHA in CD8 + T cells promote immune evasion and therapy resistance in NSCLC
by: Hao Wen, et al.
Published: (2025-07-01)